ZHELEV, ZHIVKO et al
"Docosahexaenoic Acid Sensitizes Leukemia Lymphocytes to Barasertib and Everolimus by ROS-dependent Mechanism Without Affecting the Level of ROS and Viability of Normal Lymphocytes." Anticancer Research
36.4
(2016):
1673-1682.
Web. 19 April. 2024.